Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Share-based Compensation (2016 - 2019)

Bio Key International's Share-based Compensation history spans 10 years, with the latest figure at $509528.0 for Q1 2019.

  • For Q1 2019, Share-based Compensation fell 7.35% year-over-year to $509528.0; the TTM value through Mar 2019 reached $902287.0, down 33.73%, while the annual FY2018 figure was $942692.0, 3.09% down from the prior year.
  • Share-based Compensation for Q1 2019 was $509528.0 at Bio Key International, up from $46871.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $549933.0 in Q1 2018 and bottomed at -$20140.0 in Q4 2016.
  • The 5-year median for Share-based Compensation is $156086.0 (2017), against an average of $178172.8.
  • The largest annual shift saw Share-based Compensation plummeted 130.6% in 2016 before it soared 942.95% in 2017.
  • A 5-year view of Share-based Compensation shows it stood at $65818.0 in 2015, then tumbled by 130.6% to -$20140.0 in 2016, then skyrocketed by 942.95% to $169771.0 in 2017, then tumbled by 72.39% to $46871.0 in 2018, then soared by 987.09% to $509528.0 in 2019.
  • Per Business Quant, the three most recent readings for BKYI's Share-based Compensation are $509528.0 (Q1 2019), $46871.0 (Q4 2018), and $219367.0 (Q3 2018).